
182.59 Delayed Data As of Mar 24 | ![]() Today’s Change | 92.26 Today|||52-Week Range 278.25 | -7.08% Year-to-Date |
Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug Approval Mar 23 / Zacks.com - Paid Partner Content | Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study Mar 21 / Zacks.com - Paid Partner Content |
Why Shares of Karuna Therapeutics Were Up Wednesday Mar 22 / MotleyFool.com - Paid Partner Content |
Previous close | 176.22 |
Today’s open | 175.28 |
Day’s range | 174.17 - 183.33 |
Volume | 31,984 |
Average volume (3 months) | 355,551 |
Market cap | $6.4B |
Earnings growth (last year) | -77.03% |
Earnings growth (this year) | -37.04% |
Earnings growth (next 5 years) | -18.16% |
Revenue growth (last year) | -71.22% |
P/E ratio | NM |
Price/Sales | 584.29 |
Price/Book | 5.72 |
---- |
---- |
---- |
---- |
Next reporting date | May 4, 2023 |
EPS forecast (this quarter) | -$2.75 |
Annual revenue (last year) | $10.6M |
Annual profit (last year) | -$276.3M |
Net profit margin | -2,597.88% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |